Literature DB >> 12651784

The needs of patients receiving depot antipsychotic medication within primary care.

Michael Phelan1, Ilyas Mirza.   

Abstract

BACKGROUND: Depot antipsychotic medication is a vital treatment for many people with schizophrenia. Many patients receive this medication from primary care, and have little or no contact with specialist mental health services.
OBJECTIVE: The aim of the present study was to compare the characteristics and needs of patients receiving depot medication within primary care with those receiving their medication from specialist mental health services.
METHODS: A total of 58 patients were identified from four primary care teams. Data were collected from medical records, and staff interviews were conducted using standardized interview schedules.
RESULTS: Patients receiving medication from primary care had more than twice as many health and social needs compared with those receiving medication from specialist services.
CONCLUSIONS: There are advantages for patients to receive depot medication from primary care, but the needs of the patients must be reviewed regularly, and primary care staff must have easy access to specialist mental health services.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12651784     DOI: 10.1093/fampra/20.2.126

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  3 in total

1.  Variables associated with general practitioners' knowledge about and diagnostic skills for schizophrenia.

Authors:  Cesare Turrina; Paolo Valsecchi; Silvia Bonomi; Paola Corsini; Paolo Cacciani; Gerardo Medea; Ovidio Brignoli; Emilio Sacchetti
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

2.  Objective and subjective benefits of a psychiatric pharmacist-led long-acting injectable medication training at a large, multisite organization.

Authors:  Daniel Greer; Jerome Pasquale; Jack Todd Wahrenberger
Journal:  Ment Health Clin       Date:  2020-09-30

3.  Care for patients with severe mental illness: the general practitioner's role perspective.

Authors:  Marian J T Oud; Jan Schuling; Cees J Slooff; Klaas H Groenier; Janny H Dekker; Betty Meyboom-de Jong
Journal:  BMC Fam Pract       Date:  2009-05-06       Impact factor: 2.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.